EYE » Topics » Cataract/Implant sales rose 5.2 percent to $131.7 million.
This excerpt taken from the EYE 8-K filed Oct 25, 2007.
Cataract/Implant sales rose 5.2 percent to $131.7 million.
Total intraocular lens (IOL) sales rose 6.5 percent to $74.3 million.
Monofocal IOL sales rose 7.6 percent to $61.4 million, reflecting continued strong growth of the Tecnis® IOL franchise.
Refractive IOL sales grew 1.2 percent to $12.8 million, reflecting continued demand in international markets, while domestic sales slowed.
Sales of AMOs Healon® family of viscoelastics declined
1.0 percent. Total viscoelastics sales of $30.1 million declined 2.2 percent, due primarily to the lack of a dispersive viscoelastic in the U.S. and continued pricing pressure in certain international markets.
Phacoemulsification sales increased 11.4 percent to $22.4 million. Surgical pack sales rose 12.8 percent and systems
sales increased 11.4 percent, driven by strong growth from the companys established phacoemulsification franchise and the recently launched WhiteStar SignatureTM system.
Bet you've never seen portfolio analytics like these.